CompletedPHASE1, PHASE2NCT02985320

Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sinovac Biotech Co., Ltd
Principal Investigator
Yuemei Hu
Jiangsu Provincial Center for Disease Control and Prevention
Intervention
Single-dose regimen of high dosage investigational sIPV(biological)
Enrollment
708 target
Eligibility
49 years · All sexes
Timeline
2016 – 2017

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02985320 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis →

← Back to all trials